CYTOMEGALOVIRAL INFECTION
Clinical trials for CYTOMEGALOVIRAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRAL INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine could shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine designed to protect people who have had a stem cell transplant from a common virus called CMV. The virus can cause serious illness in those with weak immune systems. The vaccine uses a harmless virus to teach the body to fight CMV, aiming to reduce infe…
Matched conditions: CYTOMEGALOVIRAL INFECTION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 08:03 UTC
-
Donor cells take on stubborn virus in transplant patients
Disease control OngoingThis study tests whether specially trained white blood cells from donors can treat a stubborn CMV infection in people who have had a stem cell transplant. About 49 participants will receive these cells to see if the infection clears. The goal is to control the virus when standard…
Matched conditions: CYTOMEGALOVIRAL INFECTION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:03 UTC